Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NOX1 | Q9Y5S8 | 7/20 | 0.43 |
| ▸ | L3MBTL1 | Q9Y468 | 3/20 | 0.43 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.43 |
| ▸ | ATM | Q13315 | 1/20 | 0.43 |
| ▸ | MEN1 | O00255 | 1/20 | 0.43 |
| ▸ | ADRA2A | P08913 | 1/20 | 0.43 |
| ▸ | ADRA2B | P18089 | 1/20 | 0.43 |
| ▸ | ADRA2C | P18825 | 1/20 | 0.43 |
| ▸ | CHRM3 | P20309 | 1/20 | 0.43 |
| ▸ | SLC6A2 | P23975 | 1/20 | 0.43 |
| ▸ | HTR2C | P28335 | 1/20 | 0.43 |
| ▸ | SLC6A4 | P31645 | 1/20 | 0.43 |
| ▸ | DRD3 | P35462 | 1/20 | 0.43 |
| ▸ | HTR2B | P41595 | 1/20 | 0.43 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.43 |
| ▸ | MAOA | P21397 | 1/20 | 0.42 |
| ▸ | HDAC4 | P56524 | 1/20 | 0.37 |
| ▸ | LMNA | P02545 | 1/20 | 0.37 |
| ▸ | MAPT | P10636 | 1/20 | 0.37 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL17109687 | 0.96 | NOX1 (0.50) | NOX1L3MBTL1KDM4EATMMEN1 | |
| SCHEMBL17109683 | 0.91 | NOX1 (0.46) | NOX1L3MBTL1KDM4EATMMEN1 | |
| SCHEMBL18595614 | 0.91 | NOX1 (0.46) | NOX1L3MBTL1KDM4EATMMEN1 | |
| SCHEMBL17109681 | 0.91 | L3MBTL1 (0.47) | NOX1L3MBTL1KDM4EATMMEN1 | |
| SCHEMBL17109674 | 0.88 | NOX1 (0.47) | NOX1L3MBTL1KDM4EATMMEN1 | |
| SCHEMBL12259323 | 0.87 | NOX1 (0.48) | NOX1L3MBTL1KDM4EATMMEN1 | |
| SCHEMBL17109684 | 0.84 | MAOA (0.56) | NOX1L3MBTL1KDM4EATMMEN1 | |
| SCHEMBL24537505 | 0.83 | L3MBTL1 (0.41) | NOX1L3MBTL1KDM4EATMMEN1 | |
| SCHEMBL17109685 | 0.83 | NOX1 (0.43) | NOX1L3MBTL1KDM4EATMMEN1 | |
| SCHEMBL25026545 | 0.82 | MAOA (0.58) | NOX1L3MBTL1KDM4EATMMEN1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9590190-B2 | Terminally activated delayed fluorescence material, a method of synthesizing the same and an OLED device using the same | SHENZHEN CHINA STAR OPTOELECTRONICS TECHNOLOGY CO., LTD (CN) | 2017-03-07 | — | — | US | disclosed |
| US-9590190-B2 | Terminally activated delayed fluorescence material, a method of synthesizing the same and an OLED device using the same | SHENZHEN CHINA STAR OPTOELECTRONICS TECHNOLOGY CO., LTD (CN) | 2017-03-07 | — | — | US | disclosed |
| US-20150270494-A1 | Terminally Activated Delayed Fluorescence Material, A Method Of Synthesizing The Same and An OLED Device Using The Same | Shenzhen China Star Optoelectronics Technology Co. Ltd. (CN) | 2015-09-24 | — | — | US | disclosed |
| US-20150270494-A1 | Terminally Activated Delayed Fluorescence Material, A Method Of Synthesizing The Same and An OLED Device Using The Same | Shenzhen China Star Optoelectronics Technology Co. Ltd. (CN) | 2015-09-24 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20150270494-A1 | Terminally Activated Delayed Fluorescence Material, A Method Of Synthesizing The Same and An OLED Device Using The Same | OCIAD1, OCIAD2, OGFOD1 | NOX1 901/4885L3MBTL1 1887/4885KDM4E 3472/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.